Severe acute respiratory syndrome coronavirus 2 and renin-angiotensin system blockers: A review and pooled analysis
- 1 December 2020
- journal article
- review article
- Published by Elsevier BV in Archives of Cardiovascular Diseases
- Vol. 113 (12), 797-810
- https://doi.org/10.1016/j.acvd.2020.09.002
Abstract
No abstract availableFunding Information
- Institut de Recherches Servier
- Fédération Française de Cardiologie
This publication has 126 references indexed in Scilit:
- Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and DiseaseInternational Journal of Peptides, 2012
- Discrepancy between Intrarenal Messenger RNA and Protein Expression of ACE and ACE2 in Human Diabetic NephropathyAmerican Journal of Nephrology, 2008
- Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entryProceedings of the National Academy of Sciences of the United States of America, 2008
- Pathology and Pathogenesis of Severe Acute Respiratory SyndromeThe American Journal of Pathology, 2007
- Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptorsKidney International, 2005
- Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II ReceptorsHypertension, 2004
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureThe New England Journal of Medicine, 2001
- Pathways for Angiotensin II Generation in Intact Human TissueHypertension, 1998
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureThe New England Journal of Medicine, 1987
- Hemodynamic and hormonal responses during captopril therapy for heart failure: Acute, chronic and withdrawal studiesThe American Journal of Cardiology, 1982